Exome Asset Management »

Rhythm Pharmaceuticals shares owned by Exome Asset Management

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.5M 41k 86.97
2024-03-31 $2.0M 46k 43.33
2023-12-31 $3.3M 72k 45.97

More positions owned by Exome Asset Management

Praxis Precision Medicines I Com New (PRAX)
Cogent Biosciences (COGT)
Enliven Therapeutics (ELVN)
Ionis Pharmaceuticals (IONS)
Spdr Series Trust State Street Spd Put Option (XBI)
Guardant Health (GH)
Cytokinetics Com New (CYTK)
Eli Lilly & Co. (LLY)
Alumis (ALMS)
Bridgebio Pharma (BBIO)
Vera Therapeutics Cl A (VERA)
Insmed Com Par $.01 (INSM)
Anthem (ELV)
Agios Pharmaceuticals (AGIO)
United Therapeutics Corporation (UTHR)

View all positions for Exome Asset Management

Top funds holding Rhythm Pharmaceuticals

RA Capital Management
BlackRock
Baker Bros. Advisors
PRIMECAP Management Company
Vanguard Portfolio Management
Vanguard Capital Management
Perceptive Advisors
State Street Corporation
Goldman Sachs Group
Westfield Capital Management Company
FMR
Polar Capital Holdings
Citadel Advisors
Geode Capital Management
Federated Investors

View all funds holding Rhythm Pharmaceuticals